Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Luvalis Pharma ApS
APS
Active
CVR 45786684
Njalsgade 21F, 2.
Manufacture of pharmaceutical preparations · NACE 2120
Est. 2025
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit
—
1 employees
EBITDA — year on year
DKK millions
NaNM
-InfinityM
-InfinityM
-InfinityM
-InfinityM
Key figures
Annual report
Revenue
—
—
EBITDA
—
—
Net profit
—
—
Total assets
—
—
Equity
—
—
Employees
1
—
Company information
Legal name
Luvalis Pharma ApS
CVR number
45786684
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
23. juli 2025
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
—
Financial year
January – December
Signatory rights
Selskabet tegnes af tre bestyrelsesmedlemmer i forening, eller af en direktør og et bestyrelsesmedlem i forening.
Company purpose
Selskabets formål er at drive virksomhed inden for udvikling, produktion og salg af farmaceutiske produkter samt hermed beslægtet virksomhed.
Contact
Address
Njalsgade 21F, 2.
Phone
+4551885722
Email
contact@luvalis.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of pharmaceutical preparations
Companies in København
All Denmark companies
Revenue
DKK millions
EBITDA
DKK millions
Income statement
DKK thousands
Item
Revenue
Staff expenses
EBITDA
Depreciation & amort.
EBIT
Net financials
Profit before tax
Tax
Net profit
Balance sheet
DKK thousands
Item
Total assets
Equity
Long-term debt
Short-term debt
Total debt
Financial ratios
5-year trend
EBITDA margin
%
This company
15.8%
Market median
-NaN% vs market
Equity ratio
%
This company
38.2%
Market median
-NaN% vs market
Return on equity
%
This company
18.4%
Market median
-NaN% vs market
Net profit margin
%
This company
8.1%
Market median
-NaN% vs market
Asset turnover
×
This company
1.12×
Market median
-NaN% vs market
Debt / equity
×
This company
0.62×
Market median
-NaN% vs market
Annual reports & filings
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
MG
Mikkel Geertsen
Chief Executive Officer
Chief Executive Officer
2025
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
BY
Bo Yde Svendsen
Chairman
2025
—
—
JH
Jonas Hammershaimb Mosbech
Deputy Chairman
2025
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Ragdoll Invest ApS
Company
33.3%
33.3%
2025
BOSV ApS
Company
33.3%
33.3%
2025
Mixin ApS
Company
33.3%
33.3%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Mixin ApS
Luvalis Pharma ApS
(this company)
Board network connections
Board members of Luvalis Pharma ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Mikkel Geertsen
Chief Executive Officer
0 companies
Bo Yde Svendsen
Chairman
0 companies
Jonas Hammershaimb Mosbech
Deputy Chairman
0 companies